Sepsis, Septic Shock Clinical Trial
Official title:
Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis
At present, people still have different opinions on choosing which kind of crystalloid solution for patients with sepsis, and there is no unified standard yet. It is necessary to conduct systematic studies on comparison of different fluid resuscitation methods on the efficacy and safety of crystalloid solution for patients with sepsis. Therefore, this study focuses on the efficacy and safety of sodium bicarbonate Ringer's solution compared with normal saline.
Status | Recruiting |
Enrollment | 450 |
Est. completion date | December 30, 2022 |
Est. primary completion date | September 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Diagnosed as sepsis or septic shock according to the definition of Sepsis-3.0 with fluid resuscitation requirement; - aged between 18 and 80, male or female; - Signed informed Consent (with delay within 24 hours). Exclusion Criteria: - Patients with hypermagnesemia; - Patients with hypothyroidism; - Patients predicted to die or discharged within 24 hours after admission; - Patients with previous history of mental illness, severe hepatic and renal insufficiency, severe cardiac disease, primary severe central nervous system lesions; - Pregnant or breast-feeding women; - Patients who have received cardiopulmonary resuscitation; - Patients who participated in other clinical trials within 30 days; - Patients have other conditions that are not appropriate for inclusion according to the researcher's judgment. |
Country | Name | City | State |
---|---|---|---|
China | Xiangya Hospital of Central South University | Changsha | Hunan |
Lead Sponsor | Collaborator |
---|---|
Xiangya Hospital of Central South University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Sequential Organ Failure Assessment(SOFA) value at 24h | ?SOFA=SOFA24h-SOFA0h | 0 hours, 24 hours | |
Secondary | Serum lactate clearance rate | (Serum lactete0h-serum lactate6h)/serum lactate0h | 0 hours, 6 hours | |
Secondary | The proportion of patients with serum lactate clearance rate>30% | the proportion of patients whose serum lactate decrease by more than 30% | 0 hours, 6 hours, 24 hours | |
Secondary | Changes in pH value over time, and the lowest pH value during hospitalization | ?pH=pH3h/6h/24h-pH0h, and the lowest pH value during hospitalization | 0 hours, 3 hours, 6 hours, 24 hours | |
Secondary | Changes in base residue (BE value) over time | ?BE=BE3h/6h/24h-BE0h | 0 hours, 3 hours, 6 hours, 24 hours | |
Secondary | Changes in serum bicarbonate(HCO3-) over time | ?HCO3-=HCO3-3h/6h/24h-HCO3-0h | 0 hours, 3 hours, 6 hours, 24 hours | |
Secondary | The proportion of patients with hyperchloremia | The proportion of patients with hyperchloremia at 3h and 24h. | 0 hours, 3 hours, 24 hours | |
Secondary | Changes in SOFA score over time | ?SOFA=SOFA24h/48h/72h-SOFA0h | 0 hours, 24 hours, 48 hours, 72 hours | |
Secondary | Changes in APACHEII score over time | ?APACHEII=APACHEII24h/48h/72h-APACHEII0h | 0 hours, 24 hours, 48 hours, 72 hours | |
Secondary | Mechanical ventilation time(h) | the length of mechanical ventilation time within 7 days | Within 7 days | |
Secondary | The proportion of patients receiving RRT | The proportion of patients receiving RRT within 7 days | Within 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03677102 -
Fluids in Septic Shock (FISSH)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04130230 -
Adjuvant Use of Neostigmine in Sepsis and Septic Shock.
|
Phase 2 | |
Completed |
NCT00525369 -
IL 6 Measurement Using a New Densitometric Bedside (POC) Test
|
N/A |